Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables

被引：199

作者：

Anderson, James R. ^{[1
]}

Cain, Kevin C. ^{[2
]}

Gelber, Richard D. ^{[3
,4
]}

机构：

[1] Univ Nebraska, Coll Publ Hlth, Omaha, NE 68182 USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 24期

关键词：

D O I：

10.1200/JCO.2008.16.1000

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3913 / 3915

页数：3

共 20 条

[11] Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival [J].

Moreton, P ;

Kennedy, B ;

Lucas, G ;

Leach, M ;

Rassam, SMB ;

Haynes, A ;

Tighe, L ;

Oscier, D ;

Fegan, C ;

Rawstron, A ;

Hillmen, P .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :2971-2979

[12] ASSESSING THE EFFECT OF TOXICITY ON PROGNOSIS - METHODS OF ANALYSIS AND INTERPRETATION [J].

PROPERT, KJ ;

ANDERSON, JR .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :868-870

[13] Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer [J].

Romond, EH ;

Perez, EA ;

Bryant, J ;

Suman, VJ ;

Geyer, CE ;

Davidson, NE ;

Tan-Chiu, E ;

Martino, S ;

Paik, S ;

Kaufman, PA ;

Swain, SM ;

Pisansky, TM ;

Fehrenbacher, L ;

Kutteh, LA ;

Vogel, VG ;

Visscher, DW ;

Yothers, G ;

Jenkins, RB ;

Brown, AM ;

Dakhil, SR ;

Mamounas, EP ;

Lingle, WL ;

Klein, PM ;

Ingle, JN ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1673-1684

[14]

Shuster JJ, 1998, J CLIN ONCOL, V16, P393

[15] A NON-PARAMETRIC GRAPHICAL REPRESENTATION OF THE RELATIONSHIP BETWEEN SURVIVAL AND THE OCCURRENCE OF AN EVENT - APPLICATION TO RESPONDER VERSUS NON-RESPONDER BIAS [J].

SIMON, R ;

MAKUCH, RW .

STATISTICS IN MEDICINE, 1984, 3 (01) :35-44

[16]

SIMON R, 1985, CANCER TREAT REP, V69, P1

[17] 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial [J].

Smith, Ian ;

Procter, Marion ;

D Gelber, Richard ;

Guillaume, Sebastien ;

Feyereislova, Andrea ;

Dowsett, Mitch ;

Goldhirsch, Aron ;

Untch, Michael ;

Mariani, Gabriella ;

Baselga, Jose ;

Kaufmann, Manfred ;

Cameron, David ;

Bell, Richard ;

Bergh, Jonas ;

Coleman, Robert ;

Wardley, Andrew ;

Harbeck, Nadia ;

Lopez, Roberto I. ;

Mallmann, Peter ;

Gelmon, Karen ;

Wilcken, Nicholas ;

Wist, Erik ;

Sanchez Rovira, Pedro ;

Piccart-Gebhart, Martine .

LANCET, 2007, 369 (9555) :29-36

[18] CHEMOTHERAPY FOR ADENOCARCINOMA OF THE LUNG (WHO III) - A RANDOMIZED STUDY OF VINDESINE VERSUS LOMUSTINE, CYCLOPHOSPHAMIDE, AND METHOTREXATE VERSUS ALL 4 DRUGS [J].

SORENSEN, JB ;

HANSEN, HH ;

DOMBERNOWSKY, P ;

BORK, E ;

MALMBERG, R ;

AABO, K ;

BODKER, B ;

HANSEN, M .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) :1169-1177

[19]

UNTCH M, ANN ONCOL

[20] COMPARING SURVIVAL OF RESPONDERS AND NONRESPONDERS AFTER TREATMENT - A POTENTIAL SOURCE OF CONFUSION IN INTERPRETING CANCER CLINICAL-TRIALS [J].

WEISS, GB ;

BUNCE, H ;

HOKANSON, JA .

CONTROLLED CLINICAL TRIALS, 1983, 4 (01) :43-52

← 1 2 →